OPEC cuts oil production, causing a spike in prices. What could we expect?

04.04.2023 14:14|Analyst Team, Conotoxia Ltd.

Oil prices rose by more than 5% on Monday (3.04) as the OPEC cartel announced an unexpected production cut. Saudi Arabia led the production cut by 500,000 barrels per day, with other countries also reducing output. OPEC representatives said the move was to ensure market stability. How might this affect the price of crude?

OPEC data

The announced production cut of 1 million b/d by the OPEC cartel has changed expectations of an oil shortage. Prior to the cut, according to OPEC's March projections and based on global orders and contracts, crude demand and supply were expected to stabilise in the first half of the year and be slightly short in the second half.

However, once the cartel cut is taken into account, shortfalls are expected in each quarter, with an average shortfall of 1.4 million b/d. By comparison, a similarly sized shortfall averaging 1.5m b/d occurred in 2021, when the price increased by more than 50%.

Source: OPEC data, own analysis

It is worth noting that OPEC does not expect a decline in oil demand due to the recession. In 2023, the cartel expects demand to increase by 2.3%. Given this, oil price rises could be expected in the coming months. However, it is difficult to determine their scale.

Source: Conotoxia MT5, XBRUSD, Daily

What does this mean for economies?

Global oil prices are particularly important for the US economy, where inflation largely follows their volatility. For this reason, it could be assumed that a slowdown in oil price increases would reduce disinflation in the USA. By contrast, in Europe, including Poland, inflation was mainly driven by increases in electricity and natural gas prices. Therefore, disinflation in European countries may be faster relative to the USA. In the event of a return of rising inflation in the US, the Fed would be faced with a tough decision to continue its tightening policy, which could negatively affect the S&P 500 index (US500).

Source: Conotoxia MT5, US500, Daily

 

Grzegorz Dróżdż, Market Analyst of Conotoxia Ltd. (Conotoxia investment service)

Materials, analysis and opinions contained, referenced or provided herein are intended solely for informational and educational purposes. Personal opinion of the author does not represent and should not be constructed as a statement or an investment advice made by Conotoxia Ltd. All indiscriminate reliance on illustrative or informational materials may lead to losses. Past performance is not a reliable indicator of future results.

CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 76,41% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.

Like the article?
Share it with friends!


See also:

Mar 31, 2023 2:11 pm

Stock market news: summary of the week 27-31.03.2023

Mar 30, 2023 1:58 pm

Will the banking sector crisis from the United States spill over into Japan?

Mar 29, 2023 1:37 pm

How might the split of Alibaba Group translate into the company's share price and the situation in the Chinese market?

Mar 28, 2023 1:55 pm

Switzerland losing its role as the centre of global finance? What could this mean for financial markets?

Mar 27, 2023 12:33 pm

Deutsche Bank and its problems. Are concerns exaggerated?

Mar 23, 2023 2:27 pm

Can oil prices continue to fall?

71.48% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.

CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 71.48% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
Trading on CFDs is provided by Conotoxia Ltd. (CySEC no.336/17), which has the right to use the Conotoxia trademark.